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Matsumoto Eosinophilia Shinshu (MES) is a rat strain that develops eosinophilia spontaneously [3] [4] [5] [6] 8] . In these rats a marked increase in peripheral blood eosinophils (>500/µl) occurs at about 9 weeks of age, with eosinophilia progressing with age until the number of eosinophils eventually exceeds the level that is characteristic of human hypereosinophilia (>1,500/µl). The abnormal eosinophilic proliferation takes place in the bone marrow and is associated with enlargement of the mesenteric lymph nodes. This enlargement is the result of infiltration of eosinophils into the lymph nodes, Eosinophil is a type of white blood cell that plays an important role in the innate immune system, especially in counteracting parasitic infections. The normal range for blood eosinophils is 40-400/µl in humans and 15-120/µl in rats. The term eosinophilia refers to conditions in which abnormally high numbers of eosinophils are found in either blood (600-1,500/µl) or tissues [1] . Eosinophilia may occur in a number of diseased conditions, which include parasitic infections, allergies, collagen vascular diseases, and neoplastic disorders. Another morbid condition distinct from these secondary eosinophilias, idiopathic hypereosinophilic syndrome (idiopathic HES), is a condition in which eosinophilia persists without any apparent etiology [7] .
where they degenerate, and release eosinophilic materials, which in turn cause granulomatous inflammation. Eosinophil-related inflammatory lesions are also observed in other organs, and they cause aortitis, inflammatory fibroid polyps in the stomach and pulmonary vasculitis with septal infiltration. These features make the MES rat a useful animal model for HES. However, the etiology of eosinophilia in the MES rat has yet to be elucidated.
In a previous study, we performed chromosomal mapping of the gene(s) associated with eosinophilia in MES rats by breeding (ACI × MES) × MES backcross progeny [2] . Blood eosinophil counts in the 328 backcrosses showed a broad distribution. Fortyone of the backcross rats with a blood eosinophil count of greater than 250/µl were classified as having eosinophilia (Group 1 in Table 1 ). Four rats with an increased number of blood neutrophils, and 29 rats with enlarged mediastinal lymph nodes were also judged as having an abnormal phenotype (Group 2). Fifty-five rats with low eosinophil and neutrophil numbers and devoid of enlarged mediastinal lymph nodes were categorized as a normal group (Group 3). Genetic linkage analysis between abnormal phenotypes and microsatellite marker loci using the chi square test revealed that the major locus for eosinophilia (eosinophilia 1; eos1) was located in the telomeric region of the q arm of chromosome 19 [2] . Significant deviations in homozygosity of the MES allele were observed in the abnormal rats (Groups 1 and 2) at marker loci including D19Rat2 (Table 1) . Thus, the D19Rat2 locus is very likely to be located close to the region of eos1. Subsequent genotyping of normal backcross rats for D19Rat2 revealed that 97 were homozygous for the MES allele at this locus. These rats (Group 4) did not develop eosinophilia despite the high likelihood that they were homozygous for eos1. The reason for the absence of eosinophilia in these 97 rats is unknown. It is possible that development of eosinophilia was either suppressed or delayed by gene(s) derived from the normal ACI strain. If it were the case, it would be very interesting to search for genetic evidence to support the existence of loci with such effects. It is also possible that eosinophilia is under the influence of multiple genes other than eos1, each with contributions smaller than that of eos1. Indeed in a previous study, quantitative trait loci (QTL) analysis for blood eosinophil count identified a suggestive QTL on chromosome 2 and a likelihood ratio statistics (LRS) peak for blood eosinophil count was located between D2Rat199 (18.5 cM) and D2Rat217 (43.4 cM). In that previous study, we examined 77 microsatellite marker loci and 5 chromosomal intervals of larger than 30 cM were left without marker loci: D1Rat181-D1Mit8, D2Mgh12-D2Rat250, D9Rat40-D9Mit10, D9Mit10-telomere, and D16Mgh4-D16Rat13. For the latter three regions, heterozygosity was observed at multiple loci in several of the MES rats used for backcross breeding. Because these MES rats developed eosinophilia despite heterozygosity at these regions, we considered it unlikely that these regions contained the gene(s) for eosinophilia.
There remained, however, the possibility that gene(s) with a weak effect were located in the interval of approximately 38 cM between D1Rat181 (103.0 cM) and D1Mit8 (141.3 cM), and the approximately 30 cM interval between D2Mgh12 (78.5 cM) and D2Rat250 (110.2 cM). We thus searched for polymorphic microsatellites between the ACI and MES rat strains and found that D1Rat123 (116.6 cM), D1Rat169 (122.1 cM), D1Rat301 (126.6 cM), D2Rat61 (88.6 cM) and D2Rat66 (99.9 cM) were polymorphic. The backcross rats were genotyped for these marker loci. In addition, the rats were genotyped for D2Mgh19 (35.4 cM), because the interval between D2Rat199 and D2Rat217, where an LRS peak for blood eosinophil count was detected, was about 25 cM. Additional genotype data at D2Mgh19, D2Rat61, and D2Rat66 did not improve the results for both the chi square test and QTL analysis. Intriguingly, however, significant deviation in heterozygosity was observed at D2Mgh19 in Group 4 rats, which were homozygous for the MES allele at D19Rat2 but remained normal (Table 1) . Thus, there appeared to be a gene on chromosome 2 of ACI rats that partially suppressed or delayed development of eosinophilia. Taking into account our previous results demonstrating the presence of a QTL for blood eosinophil count on chromosome 2, it was reasonable to conclude that there could be a second locus for eosinophilia in this region of chromosome 2 in MES rats. This locus was denoted eosinophilia 2 (eos2).
For D1Rat123, D1Rat169, and D1Rat301, significant deviations in homozygosity of the MES allele were observed in Group 1 eosinophilic rats (Table 1) . Conversely, a significant deviation in heterozygosity was observed at D1Rat301 in Group 4 rats. Furthermore, one QTL showing suggestive linkage to blood eosinophil count was found at the region on chromosome 1 with an LRS peak between D1Rat123 and D1Rat169 (Fig. 1) . These results suggested that there is a third locus for eosinophilia in this region of chro- mosome 1 in MES rats. This locus was denoted eosinophilia 3 (eos3). These data reinforce the complexity of eosinophilia in MES rats. Homozygosity at eos1 on chromosome 19 appears to be a prerequisite for the development of eosinophilia, neutrophilia, or enlarged mediastinal lymph nodes, because significant deviations in homozygosity were observed in both Group 1 and 2 rats. In the cases of chromosomes 1 and 2, however, significant deviations in homozygosity were not observed in Group 2 rats. The eos2 and eos3 genes might be associated only with eosinophilopoiesis. Further study will hopefully lead to the identification of the eos genes and the elucidation of the mechanisms involved in the development of eosinophilia in MES rats.
